CHANDRA BHAGAT PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Chandra Bhagat Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
8.49₹ 3.52
As on Dec 16, 2025, 4:01 PM IST
Chandra Bhagat Pharma Price Performance
Today's LowToday's High
₹39.65₹45.60
₹45.00
52 Weeks' Low52 Weeks' High
₹33.00₹80.00
₹45.00
Open Price
₹45.45
Prev. Close
₹41.48
Volume
18,000
Over the last 5 years, the share price of Chandra Bhagat Pharma has gained 3.17% CAGR. Over the past year, the corresponding return has been -30.77%.
Chandra Bhagat Pharma’s current P/E of 84.59x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Chandra Bhagat Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Chandra Bhagat Pharma | 2.27 | 16.28 | 4.63 | -22.41 | -30.77 | -22.05 | 3.17 |
| Sun Pharmaceutical Industries | 0.32 | 1.60 | 10.60 | 8.68 | 0.14 | 21.96 | 25.69 |
| Divi's Laboratories | -0.03 | -3.56 | 3.97 | -3.76 | 7.56 | 23.41 | 10.46 |
| Torrent Pharmaceuticals | -0.96 | -1.58 | 6.01 | 15.51 | 11.14 | 33.01 | 22.19 |
| Cipla | 0.56 | -2.53 | -3.96 | -0.40 | 3.24 | 10.95 | 13.84 |
| Dr. Reddy's Laboratories | 1.59 | 2.13 | -3.05 | -3.64 | 1.84 | 13.05 | 4.60 |
| Lupin | 2.66 | 2.83 | 3.87 | 8.55 | 3.12 | 42.53 | 16.80 |
| Zydus Lifesciences | -0.63 | -1.76 | -11.31 | -4.28 | -5.33 | 30.89 | 14.08 |
| Mankind Pharma | -1.74 | -6.00 | -17.85 | -10.30 | -20.70 | 14.01 | 8.18 |
| Aurobindo Pharma | 1.51 | -3.89 | 8.47 | 7.17 | -2.01 | 39.53 | 6.40 |
| Alkem Laboratories | 0.29 | -1.90 | 2.54 | 16.65 | 4.19 | 23.22 | 13.84 |
| Abbott India | -1.25 | -6.50 | -10.56 | -12.97 | -1.18 | 9.86 | 11.43 |
| Glenmark Pharmaceuticals | -0.48 | 4.17 | -4.83 | 17.52 | 28.48 | 67.13 | 30.30 |
| Laurus Labs | -0.88 | -1.28 | 12.95 | 52.78 | 76.64 | 37.55 | 24.16 |
| Biocon | 2.02 | -8.24 | 9.09 | 9.66 | 10.19 | 13.70 | -3.45 |
| GlaxoSmithKline Pharmaceuticals | -0.44 | 3.57 | -5.68 | -20.67 | 13.92 | 24.68 | 10.23 |
| Anthem Biosciences | 3.03 | -0.26 | -23.13 | -9.12 | -9.12 | -3.14 | -1.89 |
| Ipca Laboratories | -5.00 | -4.91 | 6.04 | 2.52 | -10.70 | 17.64 | 5.16 |
| Ajanta Pharma | -1.89 | 4.06 | 1.69 | 2.29 | -9.32 | 30.31 | 18.76 |
| J B Chemicals & Pharmaceuticals | -1.77 | -2.36 | 5.02 | 3.09 | -2.66 | 20.00 | 26.95 |
Over the last one year, Chandra Bhagat Pharma has declined 30.77% compared to peers like Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (7.56%), Torrent Pharmaceuticals (11.14%). From a 5 year perspective, Chandra Bhagat Pharma has underperformed peers relative to Sun Pharmaceutical Industries (25.69%) and Divi's Laboratories (10.46%).
Chandra Bhagat Pharma Financials
Chandra Bhagat Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 39.03 | 42.02 |
| 10 | 40.39 | 41.58 |
| 20 | 42.95 | 43.34 |
| 50 | 50.92 | 49.06 |
| 100 | 57.73 | 56.45 |
| 200 | 71.06 | 68.66 |
Chandra Bhagat Pharma Share Holding Pattern
In the latest quarter, Chandra Bhagat Pharma saw a rise in promoter holding to 72.20%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.61%, and public shareholding moved down to 27.20% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Chandra Bhagat Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 14, 2025, 1:19 AM IST | Chandra Bhagat Pharm - Un-Audited Result For Half Year Ended September 30, 2025. |
| Nov 14, 2025, 1:15 AM IST | Chandra Bhagat Pharm - Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th November 2025 For Approval Of Un-A |
| Nov 08, 2025, 2:43 AM IST | Chandra Bhagat Pharm - Board Meeting Intimation for For Approval Of Un-Audited Result For The Half Year Ended 30Th September |
| Oct 20, 2025, 10:58 PM IST | Chandra Bhagat Pharm - Disclosure |
| Oct 01, 2025, 3:45 AM IST | Chandra Bhagat Pharm - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
About Chandra Bhagat Pharma
Chandra Bhagat Pharma Ltd. is a Public Limited Listed company incorporated on 10/03/2003 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH2003PLC139534 and registration number is 139534. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 86.72 Cr. and Equity Capital is Rs. 7.55 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address323-F Bhagat Bhuvan, Dr. Ambedkar Road, Mumbai Maharashtra 400019
- Contact
Management
- Mr. Hemant Chandravadan BhagatChairman & Managing Director
- Mr. Pranav Hemant BhagatWhole Time Director
- Ms. Prachi Pranav BhagatDirector & CFO
- Mr. Ravindra Gajanan AwatiIndependent Director
- Ms. Abha Praveen DoshiIndependent Director
FAQs on Chandra Bhagat Pharma Share Price
What is the share price of Chandra Bhagat Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Chandra Bhagat Pharma is ₹45.00 as on Dec 16, 2025.
What kind of stock is Chandra Bhagat Pharma?
The Chandra Bhagat Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Chandra Bhagat Pharma?
The market cap of Chandra Bhagat Pharma is ₹33.95 Cr as on Dec 16, 2025.
What are today's High and Low prices of Chandra Bhagat Pharma?
Today’s highest and lowest price of Chandra Bhagat Pharma are ₹45.60 and ₹39.65.
What are the 52 Week High and 52 Week Low of Chandra Bhagat Pharma?
The 52-week high/low is the highest and lowest price at which Chandra Bhagat Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Chandra Bhagat Pharma is ₹80.00 and 52-week low of Chandra Bhagat Pharma is ₹33.00 as on Dec 16, 2025.
How has the Chandra Bhagat Pharma performed historically in terms of returns?
The Chandra Bhagat Pharma has shown returns of 8.49% over the past day, 16.28% for the past month, 4.63% over 3 months, -30.77% over 1 year, -22.05% across 3 years, and 3.17% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Chandra Bhagat Pharma?
P/E ratio of and PB ratio of Chandra Bhagat Pharma are 84.59 and 1.13 on Dec 16, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse